<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CD44, a cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule, exists in multiple isoforms that are generated by <z:chebi fb="40" ids="33697">RNA</z:chebi> alternative splicing </plain></SENT>
<SENT sid="1" pm="."><plain>CD44 isoforms containing exon V6 (CD44 V6) have been associated with <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the association between human B-cell activation and CD44 V6 isoform expression by analysing its expression in resting and mitogenically stimulated B cells </plain></SENT>
<SENT sid="3" pm="."><plain>Results showed that resting B cells expressed the CD44 H (no variable exon) isoform alone </plain></SENT>
<SENT sid="4" pm="."><plain>Activation of B cells [<z:chebi fb="0" ids="8116">phorbol</z:chebi> <z:chebi fb="0" ids="30807">myristate</z:chebi> <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>), surface immunoglobulin cross-linking alone or in the presence of interleukin-2 (IL-2)] induced CD44E (variable exon V8-10), R2 (VIO) and CD44 isoforms containing exons V6 and/or V7 (CD44 V6/V7) </plain></SENT>
<SENT sid="5" pm="."><plain>Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of B cells, an alternative method of B-cell activation, induced the expression of CD44 E and R2 but not CD44 V6/V7 </plain></SENT>
<SENT sid="6" pm="."><plain>These results indicate that CD44 V6/V7 expression depends on the mode of activation </plain></SENT>
<SENT sid="7" pm="."><plain>CD44 isoform expression was also investigated in a panel of EBV-negative and EBV-positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) B-cell lines </plain></SENT>
<SENT sid="8" pm="."><plain>EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells did not express CD44 </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells expressed CD44 H, R2 and E but not CD44 V6/V7 isoforms, suggesting an association between <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and CD44 isoform induction </plain></SENT>
<SENT sid="10" pm="."><plain>To determine directly the role of EBV in CD44 isoform induction, an EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell line, BL30 (negative for <z:hpo ids='HP_0000001'>all</z:hpo> isoforms of CD44), BL30 infected in vitro with the EBNA-2-defective P3HR1 (BL30/P3HR1), and the <z:mp ids='MP_0002169'>wild-type</z:mp> B95-8 strain of EBV (BL30/B95-8) were examined </plain></SENT>
<SENT sid="11" pm="."><plain>The parental BL30 cells infected with the <z:mp ids='MP_0002169'>wild-type</z:mp> EBV strain, but not with the P3HR-1 strain, expressed CD44 H, R2 and E isoforms, as seen in EBV-immortalized B cells </plain></SENT>
<SENT sid="12" pm="."><plain>These studies suggest that (1) alternative splicing of CD44 isoforms is differentially regulated depending on the mode and state of cell activation, and that (2) the CD44 V6/V7 isoforms may represent B-cell activation antigens that are induced by mitogenic stimulation but not following <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
</text></document>